News
QIAGEN bringt neuartigen Tuberkulosetest QIAreach QuantiFERON-TB für Regionen mit hoher Krankheitslast auf den Markt
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Einführung und die erfolgte CE-Kennzeichnung des Tests QIAreach® QuantiFERON®-TB zum Nachweis von Tuberkuloseinfektionen (TB)
The Non-Financial Rating Agency Vigeo-Eiris Classifies Korian 1st Company in the Healthcare Sector for its ESG1 Commitments
Korian (Paris:KORI), the leading European care services company for elderly and fragile people, welcomes the report published early October by the non-financial rating agency Vigeo-Eiris (V.E), a
Charles River and ATEM Structural Discovery Announce Strategic Partnership to Provide Clients with Cryo-EM Capabilities
Charles River Laboratories International, Inc. (NYSE: CRL) and ATEM Structural Discovery (ATEM) today announced the formation of a strategic partnership to provide clients access to ATEM’s
AMN Healthcare Names Jeffrey R. Knudson as Chief Financial Officer
AMN Healthcare (NYSE:AMN), the nation’s largest total talent solutions provider in healthcare, announced the appointment of Jeffrey R. Knudson as the company’s Chief Financial Officer. He will join
Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2021 financial results on Wednesday, November 3rd, before the market opens. A conference call has been
Charles River Laboratories Announces Two Divestitures
Charles River Laboratories International, Inc. (NYSE: CRL) announced that it has divested its Research Models and Services operations in Japan (RMS Japan) and its gene therapy CDMO site in Sweden
Vifor Pharma announces changes to its Executive Committee
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group today announced changes to its Executive Committee as current members Lee Heeson, President International, and
Acadia Healthcare Names Osei Mevs as Vice President of Government Relations
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that J.L. Osei Mevs has been named Vice President of Government Relations. In this role, Mevs will oversee the Company’s government
Acadia Healthcare Names David Keys as Chief Development Officer
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that David M. Keys, CFA, has been named Chief Development Officer. Keys will focus on mergers & acquisitions, de novo development and
Acadia Healthcare Announces Date for Third Quarter 2021 Earnings Release
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2021 results on Thursday, October 28, 2021, after the close of the market. Acadia will conduct
AMN Healthcare to Hold Third Quarter 2021 Earnings Conference Call on Thursday, November 4, 2021
AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, has scheduled a conference call to discuss its third quarter 2021
Acadia Healthcare Announces Retirement of Chief Executive Officer
The Board of Directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that Debbie Osteen will retire as CEO. Ms. Osteen will continue to serve on Acadia’s Board of Directors and
Premier, Inc. to Report Fiscal 2022 First-Quarter Results and Host Conference Call on November 2, 2021
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2022 first quarter on Tuesday, November 2, 2021, at approximately 6:30 a.m. EDT. The company will
LivaNova to Host Conference Call for Third Quarter 2021 Results
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third quarter 2021 results on Wednesday, November 3, 2021 at 12
Novocure and Zai Lab Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Treating Fields Plus Chemotherapy as First-Line Treatment in Gastric Cancer in China
Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, and Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative
Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Novocure to Report Third Quarter 2021 Financial Results
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the third quarter 2021 on Thursday, October 28, 2021, before the U.S. financial markets open. Novocure’s management
Xencor to Present Data from the Phase 1 Study of Vudalimab (XmAb®717) and Four Research Programs at the SITC Annual Meeting
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
QIAGEN erhält Auftrag vom US-Verteidigungsministerium zum weiteren Ausbau der Produktionskapazität für NeuMoDx
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass das Unternehmen einen Auftrag der US-Regierung zur Erhöhung der Produktionskapazität für Verbrauchsmaterialien
QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it had won a U.S. government contract to increase the production capacity for consumables used on its NeuMoDx 96 and 288
Chemed To Report Third-Quarter 2021 Earnings October 28, Related Conference Call To Be Held On October 29
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2021, on Thursday, October 28, 2021, following the close of trading on
Kerry Sirkka of AMN Healthcare Named American Staffing Association 2021 Volunteer of the Year
The American Staffing Association (ASA) has named Kerry Sirkka, Senior Vice President and General Manager of Local and International Solutions at AMN Healthcare, as 2021 Volunteer of the Year.
Novocure und Roche kooperieren bei klinischen Studien, um Tumortherapiefelder als Teil einer neuartigen Kombination zur Erstbehandlung von metastasierendem Bauchspeicheldrüsenkrebs zu prüfen
Novocure (NASDAQ: NVCR) gab heute den Abschluss eines Vertrags zur Zusammenarbeit mit Roche (SIX: RO. ROG; OTCQX: RHHBY) im Rahmen klinischer Studien bekannt. Ziel ist die Entwicklung von
VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that Japan’s Ministry of Health and Labor Welfare (MHLW) has granted its partner, Kissei Pharmaceutical Co., Ltd., marketing
Tánaiste announces multi-million Euro R&D support of ICON to accelerate decentralised clinical trial technology
The Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD announced today that ICON plc (NASDAQ: ICLR), a Dublin-based global provider of drug development and